Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

OBJECTIVES: In subjects with transmitted thymidine analogue mutations (TAMs), boosted PIs (PI/b) are often chosen to overcome possible resistance to the NRTI backbone. However, data to guide treatment selection are limited. Our aim was to obtain firmer guidance for clinical practice using real-world...

Descripción completa

Detalles Bibliográficos
Autores principales: Geretti, Anna Maria, White, Ellen, Orkin, Chloe, Tostevin, Anna, Tilston, Peter, Chadwick, David, Leen, Clifford, Sabin, Caroline, Dunn, David T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376847/
https://www.ncbi.nlm.nih.gov/pubmed/30544247
http://dx.doi.org/10.1093/jac/dky468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376847/
https://www.ncbi.nlm.nih.gov/pubmed/30544247
http://dx.doi.org/10.1093/jac/dky468

Ejemplares similares